Please assess the completion status of the following clinical trial:

Trial Title: Influenza Vaccine in Lung Transplant Patients - Persistence of Antibodies

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Receiving care pre- or post-lung transplant at University of Wisconsin Hospital~* Healthy adult~Exclusion Criteria:~* Allergy to eggs~* Moderate to severe febrile illness~* Active treatment for acute rejection~* Received season's influenza vaccine prior to enrollment

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Vaccine, Pre-transplant (Type: None): cohort consists of individuals waiting for lung transplantation. Inactivated influenza vaccine will be administered intramuscularly annually.
- Vaccine, Post-transplant (Type: None): Cohort consist of individuals who have received lung transplants Inactivated influenza vaccine will be administered intramuscularly annually.
- Vaccine, Healthy Controls (Type: None): Cohort consists of healthy individuals who received the influenza vaccine Inactivated influenza vaccine will be administered intramuscularly annually.

Based on this trial design, predict the completion outcome and termination type (if applicable).